Neuro2A[TRb1] mouse neuroblastoma cell line stably expressing human thyroid hormone receptor beta 1 with mutations introduced into the catalytic domain of DNA methyltransferase 3A (Dnmt3a) by CRISPR/Cas9 genome editing.
From the laboratory of Robert J. Denver, PhD, University of Michigan.
Product Type: | Cell Line |
Name: | N2a[TRb1]-Dnmt3a-Cat Domain KO Clone 2 |
Cell Type: | Neuron |
Morphology: | Neuronal |
Organism: | Mouse |
Source: | Mouse neuroblastoma |
Biosafety Level: | BSL1 |
Growth Conditions: | DMEM/F12 supplemented with hygromycin B (500 ug/mL) and 10% fetal bovine serum stripped of thyroid hormone. |
Subculturing: | Can be passaged with trypsin per standard protocols |
Cryopreservation: | DMEM/F12 growth medium with 10% DMSO |
Comments: | The Dnmt3a gene encoding the catalytic domain was targeted using CRISPR/Cas9 genome editing gRNA: CCTGGAACTGCTACATGTGCGGGCATAAGGGCAC |
Storage: | LN2 |
Shipped: | Dry Ice |
If you publish research with this product, please let us know so we can cite your paper.